US: 800.298.5699
Int'l: +1.240.747.3093
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
|
|
|
Genetic Engineering Market Research Reports
Genetic Engineering (GE), or genetic modification, is the manipulation of an organism’s DNA sequence. Using recombinant DNA technology, or gene splicing, segments of a DNA are taken out and replaced changing the genetic makeup of the organism.
Applications of GE include genetically modified foods, gene therapy, germ-line therapy and cloning. Although they have all spurred debate, one topic, which has been particularly controversial, is the use of genetically modified foods.
Genetically modified foods have found their place in today’s world with the decreasing effectiveness of synthetic pesticides used in agriculture and the world hunger crisis. Genetically modified foods can decrease the need for pesticides by increasing the crops resistance to these harmful chemicals. This can increase the harvest of many chief crops, in turn warding off starvation in many global populations.
Despite the benefits of genetically modifying food, critics have numerous concerns. One argument centers on its effect on wild populations, fearing that genetically engineered crops might transmit their modified genes to convention crops or species, creating organisms which humans have no defense for.
Another argument centers on allergenicity. There is the potential for genetically modified foods to contain allergenic proteins, making these foods dangerous for some people.
|
|
|
< prev 1 2 3 next >
Use column headings to sort
|
|
Title
|
Published
|
Price
|
|
Capitalizing on Opportunities in Cord Blood Industry Growth
By: BioInformant Worldwide, L.L.C.
... To guide industry competitors, this report considers the questions: What factors are causing a substantial number of new cord blood banks to open up business? What will be the effect of these new entrants to ...
|
more...
Search inside this report
|
8/1/2011
|
$3,995.00
|
|
Biotechnology Sector
By: First Research, Inc.
... Life Technologies, and Monsanto. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. COMPETITIVE LANDSCAPE Demand for biotechnology research in the fields of medicine, agriculture, food, and science is ...
|
more...
Search inside this report
|
3/14/2011
|
$129.00
|
|
Stem Cell Markets
By: TriMark Publications
... have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ ...
|
more...
|
6/1/2010
|
$3,400.00
|
|
Patent map and technology intelligence report. Micro-organisms/Enzymes; Propagating, Preserving Or Maintaining Micro-organisms; Genetic Engineering; Culture Media
By: Intellectual Property Exchange
... or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof; Enzymes, e.g. ligases; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, ...
|
more...
|
1/24/2010
|
$1,200.00
|
|
Genetic Engineering
By: Global Industry Analysts
... drivers, issues and concerns, and regulatory environment. Discussion on the industry’s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market ...
|
more...
|
10/1/2009
|
$950.00
|
|
The World Market for Biosimilars and the Potential for US Follow-on Biologics
By: Kalorama Information
... areas in the world and the possibility of a U.S. Market in the near future. As part of its research, this Kalormaa Information report provides the following Current market size and forecasts for biogenerics in ...
|
more...
Search inside this report
|
8/1/2009
|
$3,700.00
|
|
Choices In Cord Blood Banking: Factors Influencing Parental Decision-Making
By: BioInformant Worldwide, L.L.C.
... genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows ...
|
more...
Search inside this report
|
4/1/2009
|
$3,295.00
|
|
The 2009 Report on Gene Expression Services: World Market Segmentation by City
By: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...
|
more...
Search inside this report
|
1/5/2009
|
$795.00
|
|
The 2009-2014 Outlook for Gene Expression Services in Greater China
By: Icon Group International, Inc.
... Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities ...
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Gene Expression Services in India
By: Icon Group International, Inc.
... given across over 5,000 cities in India. For each city in question, the percent share the city is of it’s state or union territory and of India as a whole is reported. These comparative benchmarks ...
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Gene Expression Services in the United States
By: Icon Group International, Inc.
... given across some 12,900 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the ...
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
The 2009-2014 Outlook for Gene Expression Services in Japan
By: Icon Group International, Inc.
... some 1,000 cities in Japan. For each city in question, the percent share the city is of it’s prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city ...
|
more...
Search inside this report
|
12/2/2008
|
$495.00
|
|
Biopharmaceutical Expression Systems and Genetic Engineering Technology
By: BioPlan Associates, Inc.
... all the information you need to begin the shift to increased productivity. Since the 1970s little has changed in the technologies used for commercial-scale biomanufacturing (E. coli, CHO cells, or S. cerevisiae as hosts). But ...
|
more...
|
11/1/2008
|
$645.00
|
|
The 2009-2014 World Outlook for Gene Expression Services
By: Icon Group International, Inc.
... in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ...
|
more...
Search inside this report
|
9/20/2008
|
$795.00
|
|
Stem Cell Technology: Current Applications and Future Directions
By: BCC Research
... applications and documents trends that impact product demand. Segments markets by both technology and application. Covers the latest stem cell research and commercialization advances with implications for end users such as the healthcare market as ...
|
more...
|
7/1/2008
|
$4,850.00
|
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
By: Kalorama Information
... to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem ...
|
more...
Buy by the section | Search inside this report
|
3/1/2008
|
$1,995.00
|
|
Cell Therapy Markets
By: TriMark Publications
... become a part of medical practice. Unlike organs, cells are a potentially renewable resource for body repair. The goal of this TriMark Publications report is to review the market for cell therapy products using screening ...
|
more...
|
7/1/2007
|
$3,400.00
|
|
Developments in Stem Cell Research (Technical Insights)
By: Frost & Sullivan
... the same. A section on SWOT analysis of stem cell research provides the reader with some useful insights that would enable an entrant or a mature participant in the market take appropriate measures to improve ...
|
more...
|
3/31/2007
|
$6,000.00
|
|
Stem Cell - Analysis and Market Forecasts, 2006-2016
By: RRY Publications
... been named one of The Wall Street Journal’s “Best on the Street” and among the top 10 analysts in the United States by Institutional Investor. By 2016, companies supplying stem cell products should generate more ...
|
more...
|
3/1/2007
|
$2,995.00
|
|
Tissue Engineering & Stem Cell Technology Report 2007
By: Visiongain
... complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the commercial opportunities within Tissue Engineering & Stem Cell Technology. Tissue engineering, the manufacture of complete tissues ...
|
more...
|
2/28/2007
|
$2,210.00
|
|
Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet
By: IDC
... directions, including as new experimental therapies in human subjects. Stem cells are also the center of political (and as a result, financial) controversies that are affecting how stem cell research is both funded and performed. ...
|
more...
Search inside this report
|
12/22/2006
|
$500.00
|
|
New Options for Treating Neurological Disease: Stem Cell Therapy
By: Decision Resources
... diseases. Get the Answers You Need to Shape Your Strategy Stem cell therapy holds vast potential for treating degeneration or injury in areas of the body that are incapable of autonomous healing, such as the ...
|
more...
|
12/6/2006
|
$4,600.00
|
|
Chemical Genetics in Drug Discovery
By: Decision Resources
... potential, their ultimate success can be measured only when drug candidates discovered using these technologies reach the marketplace. Questions Answered in This Spectrum Report Although chemical genetics was originally developed for basic biological research, industry ...
|
more...
|
11/30/2006
|
$4,600.00
|
|
Biogenerics
By: Global Industry Analysts
... of 2007 through 2013. The report profiles 42 companies including many key and niche players worldwide such as Biocon Limited, BioPartners, BioGeneriX AG, Cangene Corporation, Cipla Ltd., Dr. Reddy's Laboratories, GeneMedix, LG Life Sciences, Pliva ...
|
more...
|
7/1/2006
|
$3,950.00
|
|
DNA Market in China: An Analysis
By: RocSearch
... a growing market in DNA technology-based products and services. The report examines the role of these technologies in shaping the landscape of the Chinese DNA market. The report studies the external and internal environment of ...
|
more...
Search inside this report
|
5/1/2006
|
$1,500.00
|
|
Title
|
Published
|
Price
|
|
|